Last CNY7.78 CNY
Change Today -0.04 / -0.51%
Volume 13.2M
600713 On Other Exchanges
Symbol
Exchange
Shanghai
As of 1:59 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

nanjing pharmaceutical co-a (600713) Snapshot

Open
CNY7.76
Previous Close
CNY7.82
Day High
CNY7.97
Day Low
CNY7.76
52 Week High
10/16/14 - CNY8.68
52 Week Low
06/20/14 - CNY5.33
Market Cap
7.0B
Average Volume 10 Days
19.5M
EPS TTM
CNY0.10
Shares Outstanding
897.4M
EX-Date
04/9/14
P/E TM
74.5x
Dividend
--
Dividend Yield
--
Current Stock Chart for NANJING PHARMACEUTICAL CO-A (600713)

Related News

No related news articles were found.

nanjing pharmaceutical co-a (600713) Related Businessweek News

No Related Businessweek News Found

nanjing pharmaceutical co-a (600713) Details

Nanjing Pharmaceutical Co., Ltd. is primarily engaged in manufacture and distribution of Chinese medicines and western drugs in China. It is involved in the pharmaceutical distribution operations, which include operation of regular chain drug stores, delivery of pharmaceuticals, supply chain management, logistics services, and others; and pharmaceutical production operations providing Chinese patent medicines, tablets, capsules, granules, solvents, bulk drugs, and others. The company is also engaged in the asset management business, which includes credit guarantee and international trading, as well as provides hotel and information services. Nanjing Pharmaceutical Co., Ltd. was founded in 1951 and is based in Nanjing, the People’s Republic of China.

Founded in 1951

nanjing pharmaceutical co-a (600713) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nanjing pharmaceutical co-a (600713) Key Developments

NanJing Pharmaceutical Company Limited Provides Earnings Guidance for the Year 2014

NanJing Pharmaceutical Company Limited provided earnings guidance for the year 2014. The company predicts a year-on-year increase of between 280% and 330% in the net profit belonging to shareholders of the listed company in 2014.

NanJing Pharmaceutical Company Seeking To Sell Asset

NanJing Pharmaceutical Company Limited (SHSE:600713) is seeking to sell entire 28.57% stake of a Beijing-based biotechnology company which valued at CNY 83.46 million through Nanjing Assets and Equity Exchange.

NanJing Pharmaceutical Company Limited, Special/Extraordinary Shareholders Meeting, Jan 29, 2015

NanJing Pharmaceutical Company Limited, Special/Extraordinary Shareholders Meeting, Jan 29, 2015., at 09:00 China Standard Time. Agenda: To discuss the proposal of electing non-independent director of Directorate, the proposal of electing Independent Director of Directorate; and to consider the proposal of issuing ultra-short-term financing bonds.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600713:CH CNY7.78 CNY -0.04

600713 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY53.35 CNY -0.33
Jointown Pharmaceutical Group Co Ltd CNY18.00 CNY -0.52
Shanghai Pharmaceuticals Holding Co Ltd CNY16.62 CNY -0.23
Wanjia Group Holdings Ltd $0.46 HKD -0.005
View Industry Companies
 

Industry Analysis

600713

Industry Average

Valuation 600713 Industry Range
Price/Earnings 81.0x
Price/Sales 0.3x
Price/Book 5.2x
Price/Cash Flow 105.7x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NANJING PHARMACEUTICAL CO-A, please visit www.njyy.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.